WALDW
MaterialsWaldencast plc - Warrants (27/07/2027)
$0.04+0.01 (+21.47%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving WALDW Today?
No stock-specific AI insight has been generated for WALDW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.02$0.12
$0.04
Fundamentals
Market Cap$366M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-0.8%
Debt / Equity—
Trading
Volume63K
Avg Volume (10D)—
Shares Outstanding—
WALDW News
20 articles- How Waldencast (WALD) Story Is Shifting As Targets Fall And Brand Hopes PersistYahoo Finance·May 4, 2026
- Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*Yahoo Finance·Apr 30, 2026
- Top Premarket GainersYahoo Finance·Apr 29, 2026
- Waldencast announces conclusion of SEC investigationYahoo Finance·Apr 28, 2026
- Promising Penny Stocks To Consider In April 2026Yahoo Finance·Apr 9, 2026
- Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible YouthfulnessYahoo Finance·Mar 24, 2026
- Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™Yahoo Finance·Mar 19, 2026
- Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™Yahoo Finance·Feb 27, 2026
- Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™Yahoo Finance·Feb 25, 2026
- Obagi Medical Launches Nu-Cil® BioStim™ Scalp SerumYahoo Finance·Oct 8, 2025
- Why BeautyHealth (SKIN) Stock Is Trading Lower TodayYahoo Finance·Sep 10, 2025
- Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical BrandYahoo Finance·Sep 10, 2025
- Waldencast price target lowered to $3 from $4 at Telsey AdvisoryYahoo Finance·Aug 21, 2025
- Waldencast Delays Earnings Release, Initiates Strategic Review Following Novaestiq AcquisitionWwd·Aug 19, 2025
- Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive TransformationYahoo Finance·Aug 18, 2025
- Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable GelsYahoo Finance·Aug 11, 2025
- Gore Range Capital Announces Sale of Novaestiq Corp. to WaldencastYahoo Finance·Jul 23, 2025
- Obagi, Milk Makeup Owner Waldencast Enters Filler Market With New AcquisitionWwd·Jul 23, 2025
- Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical BrandYahoo Finance·Jul 23, 2025
- Insiders with their considerable ownership were the key benefactors as Waldencast plc (NASDAQ:WALD) touches US$290m market capYahoo Finance·Jun 26, 2025
All 20 articles loaded
Price Data
Open$0.00
Previous Close$0.03
Day High$0.00
Day Low$0.00
52 Week High$0.12
52 Week Low$0.02
52-Week Range
$0.02$0.12
$0.04
Fundamentals
Market Cap$366M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-0.8%
Debt / Equity—
Trading
Volume63K
Avg Volume (10D)—
Shares Outstanding—
About Waldencast plc - Warrants (27/07/2027)
Waldencast Acquisition Corp. The company is headquartered in White Plains, New York.
MaterialsPERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICPERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
CIK—
Composite FIGI—
Share Class FIGI—